U.S. Interactive Media and Services Stock News

Global Industrial (GIC) has drawn fresh attention after reporting higher fourth quarter and full year 2025 sales and net income versus 2024, along with a 7.7% increase in its quarterly cash dividend to $0.28 per share. See our latest analysis for Global Industrial. Investors appear to be responding to Global Industrial’s recent earnings and dividend update, with a 1 day share price return of 2.15% and a 90 day share price return of 18.46%, while the 1 year total shareholder return of 50.40%...

On 3 March 2026, Entegris CEO David W. Reeder spoke at the Morgan Stanley Technology, Media & Telecom Conference in San Francisco, outlining the company’s positioning as a pure-play semiconductor materials provider amid an industry recovery. Reeder’s emphasis on updated guidance and local-for-local manufacturing expansion in Taiwan and Colorado highlighted how Entegris is working to reduce geopolitical exposure and reinforce supply chain resilience for global chipmakers. We’ll now examine...

In February 2026, Path Robotics announced a memorandum of understanding with Huntington Ingalls Industries to explore integrating physical AI-driven autonomous welding into HII’s shipbuilding operations, aiming to boost throughput, support the maritime industrial base, and augment the welding workforce across complex naval fabrication tasks. This collaboration highlights how advanced robotics and AI could help HII address shipyard labor constraints and production complexity, potentially...

Recent share performance and business profile Kemper (KMPR) has drawn investor attention after a mixed run in its share price, with gains over the past week but weaker performance over the past month and past 3 months. The Chicago based insurer operates through two segments: Specialty Property & Casualty Insurance and Life Insurance. It offers auto, life, accident, supplemental health, and property policies across the United States. See our latest analysis for Kemper. At a share price of...

Stryker (SYK) is back in the spotlight after using the American Academy of Orthopaedic Surgeons 2026 meeting in New Orleans to roll out new 3D printed knee components and expanded Mako SmartRobotics offerings. See our latest analysis for Stryker. The latest product launches land after a run where the share price has a 30 day share price return of 4.7% and an 11.2% share price return year to date. The 5 year total shareholder return of 72.7% points to strong longer term compounding. If this...

Why Monarch Casino & Resort is on investors’ radar Monarch Casino & Resort (MCRI) has drawn attention after recent share price moves, with the stock showing gains over the past week, month and past 3 months that contrast with its more muted year to date performance. See our latest analysis for Monarch Casino & Resort. That recent strength in the share price, including a 1-month share price return of 5.82%, sits alongside a longer run picture where total shareholder return has been 7.47% over...

If you are wondering whether Federal Realty Investment Trust is priced attractively today, this article will walk through what the current share price might imply about its underlying value. The stock most recently closed at US$110.34, with stated returns of 1.1% over 7 days, 9.1% over 30 days, 11.4% year to date and 9.5% over 1 year, as well as 17.3% over 3 years and 24.5% over 5 years. These returns sit against an evergreen backdrop rather than a single event driven catalyst. This is why...

United Parcel Service (UPS) is accelerating its Network of the Future plan by closing up to 200 manual sorting facilities and targeting roughly 30,000 voluntary job reductions in order to build a more automated, lower cost delivery network. See our latest analysis for United Parcel Service. UPS shares are trading at US$114.42, with a 30-day share price return of 7.72% and a 90-day share price return of 19.71%. The 1-year total shareholder return is 2.5% and the 3-year total shareholder return...

Klaviyo (NYSE:KVYO) has authorized a $500 million share repurchase program. The company also announced a new partnership with Google focused on AI driven customer experiences. The collaboration aims to connect search, messaging, and advertising into a more unified marketing platform for brands. Klaviyo is making these moves with its stock trading at $18.21 and a value score of 5, alongside mixed recent performance, up 14.7% over the past week but down 18.0% over the past month. Returns are...

Madison Square Garden Sports (MSGS) has drawn fresh attention after its board unanimously approved exploring a spin off that would separate the New York Knicks and New York Rangers into two independent, publicly traded companies. See our latest analysis for Madison Square Garden Sports. That spin off announcement and the CFO transition come after a strong run in the share price, with Madison Square Garden Sports posting a 90 day share price return of 48.11% and a 1 year total shareholder...

Marex Group (MRX) has drawn fresh attention after recent share price moves, with the stock showing double digit returns over the month and past 3 months. This has prompted investors to reassess the diversified financial services platform. See our latest analysis for Marex Group. The recent rally sits on top of a broader upswing, with a 30 day share price return of 10.97% and year to date share price return of 15.47%. The 1 year total shareholder return of 23.13% points to building momentum as...

OpenText recently expanded its FY26 share repurchase program by US$200 million to US$500 million and approved buying back up to 24,906,456 shares for cancellation, while also selling its Vertica analytics database business to Rocket Software for US$150 million. Together, the larger buyback and Vertica divestiture highlight a shift toward returning more capital to shareholders while sharpening the company’s focus on core information management offerings. We’ll now examine how the expanded...

NeoGenomics (NEO) has drawn fresh attention after launching RaDaR ST, a circulating tumor DNA assay designed to detect molecular residual disease in blood using patient specific panels and advanced bioinformatics. See our latest analysis for NeoGenomics. Despite the RaDaR ST launch and recent earnings and guidance updates, NeoGenomics' 30 day share price return of 21.23% and year to date share price return of 19.22% both point to fading near term momentum. At the same time, the 5 year total...

RadNet (RDNT) closed out FY 2025 with Q4 revenue of US$547.7 million and basic EPS of roughly US$0.01 loss, while trailing twelve month figures show revenue at about US$2.0 billion and basic EPS of roughly US$0.25 loss. The company has seen quarterly revenue move from US$471.4 million in Q1 2025 to US$547.7 million in Q4 2025, with basic EPS swinging between a US$0.51 loss and US$0.19 profit over the same span. This sets up a story that focuses on how quickly margins can stabilize from...

Linde (LIN) is back in focus as the stock reacts to rising natural gas costs tied to Middle East tensions and the closure of the Strait of Hormuz, a key route for global energy supplies. See our latest analysis for Linde. Beyond the immediate reaction to energy cost concerns, Linde’s share price has shown strong momentum, with an 11.46% 30 day share price return and an 18.70% year to date share price return. Over a longer horizon, the 1 year total shareholder return of 11.67% and 5 year total...

In late February 2026, Trupanion reported its full-year 2025 results, highlighting a return to profitability with net income of US$19.4 million and surpassing US$1.00 billion in annual subscription revenue driven by pricing aligned to rising veterinary costs and improved operating margins. The company also issued an optimistic 2026 outlook, projecting total revenue of about US$1.55–US$1.58 billion and targeting adjusted operating income growth of roughly 19%, while exploring lower-priced...

In recent days, escalating conflict involving Iran and effective disruption around the Strait of Hormuz have pushed global oil prices sharply higher, focusing attention on Exxon Mobil’s large upstream operations. At the same time, Exxon Mobil confirmed that director Jeffrey W. Ubben will not seek re-election at the May 2026 shareholder meeting, though his departure is described as unrelated to the company. These developments highlight how sudden geopolitical supply risks can reinforce the...

Spire (SR) has drawn fresh attention after terminating the certificate of designations for its 5.90% Series A Cumulative Redeemable Perpetual Preferred Stock, along with recent earnings and dividend updates in the natural gas utilities sector. See our latest analysis for Spire. That change to Spire’s capital structure comes as the share price trades at US$91.66, with a 30 day share price return of 8.49% and a 1 year total shareholder return of 22.45%. The 5 year total shareholder return of...

In late February 2026, Pfizer and Astellas reported that PADCEV plus Keytruda cut the risk of tumor recurrence, progression or death in cisplatin-eligible muscle-invasive bladder cancer patients versus standard chemotherapy, while Pfizer also secured full FDA approval for BRAFTOVI-based combination therapy in first-line BRAF V600E-mutant metastatic colorectal cancer. Together, these oncology advances strengthen Pfizer’s presence in high-need cancer settings and may help offset pressure from...

Range Resources (RRC) is back in focus after reporting 2025 results with record operational efficiencies, setting a new 2026 capital plan and production guidance, and lifting its quarterly dividend payout to shareholders. See our latest analysis for Range Resources. The recent earnings beat, operational records and dividend increase appear to be feeding into solid momentum, with a 7 day share price return of 8.6% and a year to date share price return of 18.6%, while the 5 year total...

Bio-Rad Laboratories (BIO) has been drawing attention after a mixed stretch for the share price, with gains over the past year but declines over the past 3 months and year to date. See our latest analysis for Bio-Rad Laboratories. Recent trading has been choppy, with a 4.23% 7 day share price return following a weaker 30 day share price return of a 4.80% decline. A 12.23% decline over 90 days points to fading momentum despite a 9.02% 1 year total shareholder return. If this mixed performance...

Event context and recent share performance Maximus (MMS) has come onto investors’ radar after a period of mixed share performance. The stock is down roughly 22% over the past month and about 15% over the past 3 months. See our latest analysis for Maximus. Against this recent slide, Maximus still has a 1 year total shareholder return of 16.64%. However, the 3 year and 5 year total shareholder returns of 6.02% and 6.59% declines suggest fading longer term momentum. If Maximus’ move has you...

Conagra Brands (NYSE:CAG) has added John Mulligan and Pietro Satriano to its board of directors. Mulligan and Satriano bring leadership experience from Target, McDonald's, US Foods, and Loblaw. The appointments signal a focus on retail operations, finance, and foodservice expertise at the board level. Conagra Brands, trading at $19.18, sits in a challenging spot after a 20.8% decline over the past year and a 33.5% decline over five years, even with a 10.9% gain year to date. For investors...

In February 2026, Centerspace reported fourth-quarter 2025 results showing sales of US$66.62 million and a net loss of US$18.38 million, alongside full-year sales of US$273.66 million and net income of US$17.59 million. The company paired this with 2026 guidance calling for a diluted net loss per share of US$0.49 to US$0.19, signaling a potential step back after returning to profitability in 2025. Next, we’ll examine how Centerspace’s return to profit in 2025 but projected loss in 2026...